Biomarin Pharmaceutical (BMRN) EBIT Growth (3y) (2012 - 2026)
Biomarin Pharmaceutical (BMRN) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
16.35% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-50.81% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Biomarin Pharmaceutical |
10.52 Bn |
8.29 Bn |
571.21 Mn |
27.60% |
| Date | Value |
|---|
| Mar 31, 2026 |
27.60% |
| Dec 31, 2025 |
-50.49% |
| Sep 30, 2025 |
-168.32% |
| Jun 30, 2025 |
91.95% |
| Mar 31, 2025 |
17.70% |
| Dec 31, 2024 |
64.48% |
| Sep 30, 2024 |
60.57% |
| Jun 30, 2024 |
117.72% |
| Mar 31, 2024 |
52.21% |
| Dec 31, 2023 |
36.25% |
| Sep 30, 2023 |
36.54% |
| Jun 30, 2023 |
53.28% |
| Mar 31, 2023 |
-15.91% |
| Dec 31, 2022 |
-12.62% |
| Sep 30, 2022 |
-37.56% |
| Jun 30, 2022 |
43.37% |
| Mar 31, 2022 |
65.65% |
| Dec 31, 2021 |
-19.98% |
| Sep 30, 2021 |
-50.09% |
| Jun 30, 2021 |
35.03% |
